tiprankstipranks
Trending News
More News >
Ascentage Pharma Group International (HK:6855)
:6855
US Market

Compare Ascentage Pharma Group International (6855) vs. Competitors

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ascentage Pharma Group International
HK$50.90
HK$18.26B
-12.51
44.45%
1 Buy
0 Hold
0 Sell
Moderate Buy
InnoCare Pharma Ltd.
HK$11.62
HK$17.44B
-82.29
110.16%
4 Buy
1 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$22.14
HK$39.64B
-21.58
101.27%
0 Buy
1 Hold
0 Sell
Hold
Everest Medicines Ltd.
HK$51.50
HK$14.32B
-18.15
-1.24%
Simcere Pharmaceutical Group Limited
HK$12.11
HK$31.43B
31.37
70.66%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$58.60
HK$31.90B
35.30
244.87%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6855
Ascentage Pharma Group International
49.04
13.34
37.37%
HK:9969
InnoCare Pharma Ltd.
11.62
6.09
110.16%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
22.14
11.14
101.27%
HK:1952
Everest Medicines Ltd.
39.80
-1.35
-3.28%
HK:2096
Simcere Pharmaceutical Group Limited
11.69
4.88
71.66%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
57.80
40.82
240.40%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts